Aerovate Therapeutics, Inc. (NASDAQ: AVTE), relating to a proposed merger with Jade Biosciences. Under the terms of the agreement, pre-merger Aerovate stockholders are expected to own approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback